NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

Kind of sounds like that Doc hopes for -L to be available on a RTT type basis while efficacy is proved.

There is the balance between access and getting more data and validation of efficacy.[color=red] And I hope there will be a way in the future to be able to do both. To be able to allow patients to have access to treatments and then have the neuro-oncology community continue to test agents and come up with innovative trials to prove or disprove efficacy. And one of the problems is unless you can get access to the agent it is very difficult to do that. So perhaps a way to open access to DCvax would be beneficial to the field.

You know a lot of patients now in the neuro oncology community, they're just taking a lot of different off-label drugs that have even less proof of efficacy for glioblastoma but it is FDA approved for another indication and they want tot try it. Neuroc-oncologists are giving it. I guess my hope for DCVax is that it maybe could be accessible so that we can do these studies and patients the Right to Try